Global Pharmaceutical Excipients Market Growth 2022-2028

The global Pharmaceutical Excipients market size is predicted to grow from US$ 46800 million in 2025 to US$ 63880 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.

Global Pharmaceutical Excipients key players include Hnerkang、DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik, etc. Global top ten manufacturers hold a share about 7%. North America is the largest market, with a share about 35%, followed by Europe and Asia Pacific, have a share over 60 percent.

With the continuous progress and innovation of the pharmaceutical industry, the market demand for pharmaceutical excipients is also growing. Especially in the context of the improvement of global health awareness, the intensification of an aging society, and the increasing demand for efficient and safe drugs, the application scenarios of pharmaceutical excipients are becoming more and more extensive, and the market demand is expanding.

With the rise of new treatment methods such as biopharmaceuticals, personalized drugs, and targeted therapy, higher requirements are placed on the functions and performance of pharmaceutical excipients. For example, biologics and targeted drugs require specific excipients to improve the stability of drugs, improve the efficacy, or prolong the release time of drugs. In addition, the improvement of regulations and the improvement of industry standards have also promoted the standardized development of the pharmaceutical excipients market. In some regions, the government's supervision of drug quality has become more stringent, prompting pharmaceutical companies to pay more attention to quality and safety in the selection of pharmaceutical excipients, thereby promoting the demand for high-performance excipients.

LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Excipients Industry Forecast” looks at past sales and reviews total world Pharmaceutical Excipients sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients sales for 2025 through 2031. With Pharmaceutical Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Excipients market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Starch and Derivatives
Sucrose
Cellulose and Derivatives
Dextrose
Polyols
Inorganic Salts
Others

Segmentation by Application:
Oral Formulations
Topical Formulations
Parenteral Formulations
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DowDuPont (FMC)
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Südzucker AG
Mitsubishi
Hunan ER-KANG
Anhui Sunhere
Tianjin Chase Sun
Xiwang Group
ShengTai Group
Nanjing Well Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Excipients market?

What factors are driving Pharmaceutical Excipients market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Excipients market opportunities vary by end market size?

How does Pharmaceutical Excipients break out by Type, by Application?


1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Excipients Annual Sales 2020-
2.1.2 World Current & Future Analysis for Pharmaceutical Excipients by Geographic Region, 2020, 2024 &
2.1.3 World Current & Future Analysis for Pharmaceutical Excipients by Country/Region, 2020, 2024 &
2.2 Pharmaceutical Excipients Segment by Type
2.2.1 Starch and Derivatives
2.2.2 Sucrose
2.2.3 Cellulose and Derivatives
2.2.4 Dextrose
2.2.5 Polyols
2.2.6 Inorganic Salts
2.2.7 Others
2.3 Pharmaceutical Excipients Sales by Type
2.3.1 Global Pharmaceutical Excipients Sales Market Share by Type (2020-2025)
2.3.2 Global Pharmaceutical Excipients Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pharmaceutical Excipients Sale Price by Type (2020-2025)
2.4 Pharmaceutical Excipients Segment by Application
2.4.1 Oral Formulations
2.4.2 Topical Formulations
2.4.3 Parenteral Formulations
2.4.4 Other
2.5 Pharmaceutical Excipients Sales by Application
2.5.1 Global Pharmaceutical Excipients Sale Market Share by Application (2020-2025)
2.5.2 Global Pharmaceutical Excipients Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pharmaceutical Excipients Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pharmaceutical Excipients Breakdown Data by Company
3.1.1 Global Pharmaceutical Excipients Annual Sales by Company (2020-2025)
3.1.2 Global Pharmaceutical Excipients Sales Market Share by Company (2020-2025)
3.2 Global Pharmaceutical Excipients Annual Revenue by Company (2020-2025)
3.2.1 Global Pharmaceutical Excipients Revenue by Company (2020-2025)
3.2.2 Global Pharmaceutical Excipients Revenue Market Share by Company (2020-2025)
3.3 Global Pharmaceutical Excipients Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Excipients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Excipients Product Location Distribution
3.4.2 Players Pharmaceutical Excipients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pharmaceutical Excipients by Geographic Region
4.1 World Historic Pharmaceutical Excipients Market Size by Geographic Region (2020-2025)
4.1.1 Global Pharmaceutical Excipients Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pharmaceutical Excipients Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pharmaceutical Excipients Market Size by Country/Region (2020-2025)
4.2.1 Global Pharmaceutical Excipients Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pharmaceutical Excipients Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Excipients Sales Growth
4.4 APAC Pharmaceutical Excipients Sales Growth
4.5 Europe Pharmaceutical Excipients Sales Growth
4.6 Middle East & Africa Pharmaceutical Excipients Sales Growth
5 Americas
5.1 Americas Pharmaceutical Excipients Sales by Country
5.1.1 Americas Pharmaceutical Excipients Sales by Country (2020-2025)
5.1.2 Americas Pharmaceutical Excipients Revenue by Country (2020-2025)
5.2 Americas Pharmaceutical Excipients Sales by Type (2020-2025)
5.3 Americas Pharmaceutical Excipients Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Excipients Sales by Region
6.1.1 APAC Pharmaceutical Excipients Sales by Region (2020-2025)
6.1.2 APAC Pharmaceutical Excipients Revenue by Region (2020-2025)
6.2 APAC Pharmaceutical Excipients Sales by Type (2020-2025)
6.3 APAC Pharmaceutical Excipients Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Excipients by Country
7.1.1 Europe Pharmaceutical Excipients Sales by Country (2020-2025)
7.1.2 Europe Pharmaceutical Excipients Revenue by Country (2020-2025)
7.2 Europe Pharmaceutical Excipients Sales by Type (2020-2025)
7.3 Europe Pharmaceutical Excipients Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Excipients by Country
8.1.1 Middle East & Africa Pharmaceutical Excipients Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pharmaceutical Excipients Revenue by Country (2020-2025)
8.2 Middle East & Africa Pharmaceutical Excipients Sales by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Excipients Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients
10.3 Manufacturing Process Analysis of Pharmaceutical Excipients
10.4 Industry Chain Structure of Pharmaceutical Excipients
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Excipients Distributors
11.3 Pharmaceutical Excipients Customer
12 World Forecast Review for Pharmaceutical Excipients by Geographic Region
12.1 Global Pharmaceutical Excipients Market Size Forecast by Region
12.1.1 Global Pharmaceutical Excipients Forecast by Region (2026-2031)
12.1.2 Global Pharmaceutical Excipients Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pharmaceutical Excipients Forecast by Type (2026-2031)
12.7 Global Pharmaceutical Excipients Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 DowDuPont (FMC)
13.1.1 DowDuPont (FMC) Company Information
13.1.2 DowDuPont (FMC) Pharmaceutical Excipients Product Portfolios and Specifications
13.1.3 DowDuPont (FMC) Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 DowDuPont (FMC) Main Business Overview
13.1.5 DowDuPont (FMC) Latest Developments
13.2 JRS Pharma
13.2.1 JRS Pharma Company Information
13.2.2 JRS Pharma Pharmaceutical Excipients Product Portfolios and Specifications
13.2.3 JRS Pharma Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 JRS Pharma Main Business Overview
13.2.5 JRS Pharma Latest Developments
13.3 BASF
13.3.1 BASF Company Information
13.3.2 BASF Pharmaceutical Excipients Product Portfolios and Specifications
13.3.3 BASF Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BASF Main Business Overview
13.3.5 BASF Latest Developments
13.4 Lubrizol
13.4.1 Lubrizol Company Information
13.4.2 Lubrizol Pharmaceutical Excipients Product Portfolios and Specifications
13.4.3 Lubrizol Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lubrizol Main Business Overview
13.4.5 Lubrizol Latest Developments
13.5 Ashland
13.5.1 Ashland Company Information
13.5.2 Ashland Pharmaceutical Excipients Product Portfolios and Specifications
13.5.3 Ashland Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ashland Main Business Overview
13.5.5 Ashland Latest Developments
13.6 Croda International
13.6.1 Croda International Company Information
13.6.2 Croda International Pharmaceutical Excipients Product Portfolios and Specifications
13.6.3 Croda International Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Croda International Main Business Overview
13.6.5 Croda International Latest Developments
13.7 Roquette
13.7.1 Roquette Company Information
13.7.2 Roquette Pharmaceutical Excipients Product Portfolios and Specifications
13.7.3 Roquette Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Roquette Main Business Overview
13.7.5 Roquette Latest Developments
13.8 Shin-Etsu
13.8.1 Shin-Etsu Company Information
13.8.2 Shin-Etsu Pharmaceutical Excipients Product Portfolios and Specifications
13.8.3 Shin-Etsu Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shin-Etsu Main Business Overview
13.8.5 Shin-Etsu Latest Developments
13.9 Evonik
13.9.1 Evonik Company Information
13.9.2 Evonik Pharmaceutical Excipients Product Portfolios and Specifications
13.9.3 Evonik Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Evonik Main Business Overview
13.9.5 Evonik Latest Developments
13.10 Associated British Foods
13.10.1 Associated British Foods Company Information
13.10.2 Associated British Foods Pharmaceutical Excipients Product Portfolios and Specifications
13.10.3 Associated British Foods Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Associated British Foods Main Business Overview
13.10.5 Associated British Foods Latest Developments
13.11 Südzucker AG
13.11.1 Südzucker AG Company Information
13.11.2 Südzucker AG Pharmaceutical Excipients Product Portfolios and Specifications
13.11.3 Südzucker AG Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Südzucker AG Main Business Overview
13.11.5 Südzucker AG Latest Developments
13.12 Mitsubishi
13.12.1 Mitsubishi Company Information
13.12.2 Mitsubishi Pharmaceutical Excipients Product Portfolios and Specifications
13.12.3 Mitsubishi Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Mitsubishi Main Business Overview
13.12.5 Mitsubishi Latest Developments
13.13 Hunan ER-KANG
13.13.1 Hunan ER-KANG Company Information
13.13.2 Hunan ER-KANG Pharmaceutical Excipients Product Portfolios and Specifications
13.13.3 Hunan ER-KANG Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hunan ER-KANG Main Business Overview
13.13.5 Hunan ER-KANG Latest Developments
13.14 Anhui Sunhere
13.14.1 Anhui Sunhere Company Information
13.14.2 Anhui Sunhere Pharmaceutical Excipients Product Portfolios and Specifications
13.14.3 Anhui Sunhere Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Anhui Sunhere Main Business Overview
13.14.5 Anhui Sunhere Latest Developments
13.15 Tianjin Chase Sun
13.15.1 Tianjin Chase Sun Company Information
13.15.2 Tianjin Chase Sun Pharmaceutical Excipients Product Portfolios and Specifications
13.15.3 Tianjin Chase Sun Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Tianjin Chase Sun Main Business Overview
13.15.5 Tianjin Chase Sun Latest Developments
13.16 Xiwang Group
13.16.1 Xiwang Group Company Information
13.16.2 Xiwang Group Pharmaceutical Excipients Product Portfolios and Specifications
13.16.3 Xiwang Group Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Xiwang Group Main Business Overview
13.16.5 Xiwang Group Latest Developments
13.17 ShengTai Group
13.17.1 ShengTai Group Company Information
13.17.2 ShengTai Group Pharmaceutical Excipients Product Portfolios and Specifications
13.17.3 ShengTai Group Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 ShengTai Group Main Business Overview
13.17.5 ShengTai Group Latest Developments
13.18 Nanjing Well Pharmaceutical
13.18.1 Nanjing Well Pharmaceutical Company Information
13.18.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients Product Portfolios and Specifications
13.18.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Nanjing Well Pharmaceutical Main Business Overview
13.18.5 Nanjing Well Pharmaceutical Latest Developments
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings